Animol Discovery
PrivateLast Round
Series C
Feb 3, 2025
Est. Valuation
$99.5M
Total Funding Raised
$44.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Animol Discovery operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series C round in February 2025.
Animol Discovery is a biotechnology company that develops animal drug discovery technology to discover small-molecule active pharmaceutical ingredients.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Animol Discovery Comparables
Compare Animol Discovery with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ASTRA Therapeutics | 83% | |
| Vetigenics Inc. | 78% | |
| Peptidus Biotech | 74% |
For institutional investors. Book with your work email.
Animol Discovery Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 3, 2025 | ||||
| Series B | Jul 28, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Animol Discovery Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Anterra Capital | Series B, Accelerator |
| Novalis LifeSciences | Series C, Series B |
| Finistere Ventures | Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 61% MoM, reaching 2.7K.
- Jun 21, 2026
Monthly visitors increased 41% MoM.
For institutional investors. Book with your work email.
Animol Discovery Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Animol Discovery's valuation, stock price, and market status.
Is Animol Discovery a public or private company?
Animol Discovery is a private company.
What is the current stock price of Animol Discovery?
Animol Discovery is a private company, so its shares have no public market price. Caplight tracks Animol Discovery's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Animol Discovery worth (valuation)?
Animol Discovery's valuation is estimated at $99.5M based on funding round data.
Can I buy Animol Discovery stock?
Animol Discovery shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Animol Discovery's last funding round?
Animol Discovery's most recent funding round was Series C on February 3, 2025.
Who are the main investors in Animol Discovery?
Key investors in Animol Discovery include Anterra Capital, Novalis LifeSciences.
Will Animol Discovery IPO soon?
No public IPO plans have been announced for Animol Discovery.
How can I track Animol Discovery secondary market activity?
Caplight tracks bids, offers, and trades in Animol Discovery's shares on secondary markets.